drugset / Trial / NCT04787419

Probiotics in Pediatric Chronic Cholestasis

NCT04787419 ↗

Phase 2/3 Unknown 60 enrolled Indonesia University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

double blinded RCT (probiotics vs placebo) given to pediatric patients with chronic cholestasis for 4 weeks duration. baseline characteristics (antropometry, gastrointestinal symptoms, laboratory examinations) would be compared pre vs post treatment

Timeline

Start
2020-09-01
Primary completion
2023-12-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject lacto-B Unknown 1 g —

Indications